Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Walmart WMT Selected as Top Dividend Stock for Retirement Portfolios Amid Analyst Price Target Adjustments ConocoPhillips Shares Advance as Oil Prices Rebound Barclays Raises Energy Transfer ET Price Target Citing Undervaluation Quarles Earns Mergers Acquisitions MidMarket Deals of the Year Recognition for Portfolio Company Sale Telecoms CEO Warns Europe Underestimates Risks of US Dominance in Satellites and AI SFIX Q1 2026 Earnings EPS Beats Expectations Amid Narrowed Loss Stock Slightly Down NSP Q1 2026 Earnings EPS Surges Past Estimates Shares Rally 4 ZEPP Q3 2025 Earnings Narrowing Loss Without Revenue Disclosure VMD Q1 2026 Earnings EPS Misses Estimates but Positive Stock Response Signals Underlying Confidence WD40 Company WDFC Q1 2026 Earnings EPS Beats Estimates as Company Maintains Steady Growth Hilton Worldwide HLT Surges 35 as Hospitality Demand Strengthens Stitch Fix SFIX Bounces Analyzing the 345 Uptick and Key Levels Brandywine Realty Trust BDN Holds Near 300 as Bulls Test Resistance Zone Scholar Rock SRRK Surges Over 6 Key Levels to Watch After the Jump Market Odds of Fed Rate Hike Rise After Inflation Data Rate Cuts Pushed to 2027 Morrisons Announces Potential Closure of 100 Stores Amid Rising Cost Pressures Why Taiwan Became the Defining Issue in the TrumpXi Talks Rising Retirement Age Financial Pressures Keep Older Workers in the Workforce Ray Dalio Reflects on 4000 Loan from Father After Early Career Mistake That Nearly Undid Bridgewater Associates SpaceXs IPO Ambitions Highlight Growing Dependence on Starlink for Revenue and Profit Nvidia Earnings Call in Focus Geopolitical Commentary and China Chip Strategy After Xi Summit China Prepares Humanoid Robots for Employment as Part of Industrial Strategy Nexpace Launches NXPC Buyback Program to Support UserDriven Growth in MapleStory Universe Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment